BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6265067)

  • 1. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures.
    Gazdar AF; Zweig MH; Carney DN; Van Steirteghen AC; Baylin SB; Minna JD
    Cancer Res; 1981 Jul; 41(7):2773-7. PubMed ID: 6265067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collapse of Intra-Tumor Cooperation Induced by Engineered Defector Cells.
    Archetti M
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy.
    Li B; Yang L
    Nutrients; 2021 May; 13(5):. PubMed ID: 34067957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine metabolism: energy homeostasis, immunity and cancer biology.
    Kazak L; Cohen P
    Nat Rev Endocrinol; 2020 Aug; 16(8):421-436. PubMed ID: 32493980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Metabolic Rewiring in Lung Squamous Cell Carcinoma.
    Paes de Araújo R; Bertoni N; Seneda AL; Felix TF; Carvalho M; Lewis KE; Hasimoto ÉN; Beckmann M; Drigo SA; Reis PP; Mur LAJ
    Metabolites; 2019 Mar; 9(3):. PubMed ID: 30866469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into gemcitabine resistance and the potential for therapeutic monitoring.
    Gebregiworgis T; Bhinderwala F; Purohit V; Chaika NV; Singh PK; Powers R
    Metabolomics; 2018 Nov; 14(12):156. PubMed ID: 30830412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.
    Puchades-Carrasco L; Jantus-Lewintre E; Pérez-Rambla C; García-García F; Lucas R; Calabuig S; Blasco A; Dopazo J; Camps C; Pineda-Lucena A
    Oncotarget; 2016 Mar; 7(11):12904-16. PubMed ID: 26883203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.
    Mathé EA; Patterson AD; Haznadar M; Manna SK; Krausz KW; Bowman ED; Shields PG; Idle JR; Smith PB; Anami K; Kazandjian DG; Hatzakis E; Gonzalez FJ; Harris CC
    Cancer Res; 2014 Jun; 74(12):3259-70. PubMed ID: 24736543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the creatine kinases and some historical perspectives.
    Qin W; Khuchua Z; Cheng J; Boero J; Payne RM; Strauss AW
    Mol Cell Biochem; 1998 Jul; 184(1-2):153-67. PubMed ID: 9746319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas.
    Joseph J; Cardesa A; Carreras J
    Br J Cancer; 1997; 76(5):600-5. PubMed ID: 9303358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.
    Hirano T; Fujioka K; Franzèn B; Okuzawa K; Uryu K; Shibanuma H; Numata K; Konaka C; Ebihara Y; Takahashi M; Kato H; Auer G
    Br J Cancer; 1997; 75(7):978-85. PubMed ID: 9083332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ubiquitous mitochondrial creatine kinase expression in HeLa cells by an antisense oligodeoxynucleotide.
    Enjolras N; Godinot C
    Mol Cell Biochem; 1997 Feb; 167(1-2):113-25. PubMed ID: 9059988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.
    Zhao J; Schmieg FI; Simmons DT; Molloy GR
    Mol Cell Biol; 1994 Dec; 14(12):8483-92. PubMed ID: 7969181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine kinase in non-muscle tissues and cells.
    Wallimann T; Hemmer W
    Mol Cell Biochem; 1994; 133-134():193-220. PubMed ID: 7808454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of native creatine kinase B in insect cells using a baculovirus expression vector.
    de Kok YJ; Geurds MP; Sistermans EA; Usmany M; Vlak JM; Wieringa B
    Mol Cell Biochem; 1995 Feb; 143(1):59-65. PubMed ID: 7776959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
    Gosney JR; Gosney MA; Lye M; Butt SA
    Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine differentiation in lung carcinoma.
    Addis BJ
    Thorax; 1995 Feb; 50(2):113-5. PubMed ID: 7701446
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.
    Zeltzer PM; Schneider SL; Von Hoff DD
    J Neurooncol; 1984; 2(1):35-45. PubMed ID: 6381659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of the biology of small cell carcinoma of the lung.
    Gazdar AF; Carney DN; Minna JD
    Yale J Biol Med; 1981; 54(3):187-93. PubMed ID: 6270917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for production of monoclonal antibodies with specificity for human lung cancer cells.
    Minna JD; Cuttitta F; Rosen S; Bunn PA; Carney DN; Gazdar AF; Krasnow S
    In Vitro; 1981 Dec; 17(12):1058-70. PubMed ID: 6172365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.